Emicizumab and Etodolac Extended-Release Tablets
Determining the interaction of Emicizumab and Etodolac Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: emicizumab
Brand name: Hemlibra, Hemlibra 105 mg/07 mL, Hemlibra 60 mg/04 mL
Synonyms: n.a.
Generic Name: etodolac
Brand name: Lodine, Lodine XL
Synonyms: Etodolac
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Emicizumab-Etomidate
- Emicizumab-Etonogestrel
- Emicizumab-Etonogestrel implant
- Emicizumab-Etonogestrel Intradermal
- Emicizumab-Etopophos
- Emicizumab-Etopophos (Etoposide Injection)
- Etodolac Extended-Release Tablets-Emicizumab-kxwh
- Etodolac Extended-Release Tablets-Emicizumab-kxwh Subcutaneous
- Etodolac Extended-Release Tablets-Emla
- Etodolac Extended-Release Tablets-Emla Topical
- Etodolac Extended-Release Tablets-Emo-Cort Scalp Solution Topical application
- Etodolac Extended-Release Tablets-Emo-Cort Topical application